NK
Nagamani Kaperla
About Nagamani Kaperla
Data last updated:
Nagamani Kaperla has 7 years in corporate governance. Holds Additional Director and Director roles. Currently with 2 companies, including Fugen Laboratories Private Limited and Manvi Biopharma Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹14.88 Cr; the largest is Manvi Biopharma Private Limited at ₹13.97 Cr (FY 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Manvi Biopharma Private Limited U74999TG2018PTC127913 | Director | 26 Oct 2018 | 2018 | ₹13.97 Cr (FY 2021) | Active |
 Fugen Laboratories Private Limited U24231TG2005PTC045207 | Additional Director | 11 Jan 2021 | 2005 | ₹91.8 Lakh (FY 2021) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nagamani Kaperla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nagamani Kaperla
Nagamani Kaperla has 7 years in corporate governance. Holds Additional Director and Director roles. Currently with 2 companies, including Fugen Laboratories Private Limited and Manvi Biopharma Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹14.88 Cr; the largest is Manvi Biopharma Private Limited at ₹13.97 Cr (FY 2021).
Nagamani Kaperla is associated with 2 companies as Additional Director and Director, including Manvi Biopharma Private Limited (₹13.97 Cr), Fugen Laboratories Private Limited (₹91.8 Lakh).
Nagamani Kaperla has expertise in General Business.
Nagamani Kaperla has 7 years in corporate governance.
By reported revenue, the largest current company of Nagamani Kaperla is Manvi Biopharma Private Limited, with revenue of ₹13.97 Cr (FY 2021).
The 2 current companies of Nagamani Kaperla that report revenue have a combined latest revenue of ₹14.88 Cr.
Nagamani Kaperla currently holds positions at 2 companies: Manvi Biopharma Private Limited (₹13.97 Cr), Fugen Laboratories Private Limited (₹91.8 Lakh).